WallachBeth Capital, a leading provider of capital markets and institutional execution services, announced the closing of the initial public offering of …
Capital Markets
WallachBeth Capital, LLC Acts as the Sole Placement Agent for SmartZyme’s Ongoing Series B-1 Offering
Jersey City, NJ - March 14, 2018 - WallachBeth Capital, a leading provider of institutional execution services, is acting as the sole placement agent for …
WallachBeth Capital acts as Co-Book-Running Manager for Co-Diagnostics in its Initial Public Offering
NEW YORK, NY— July 17, 2017 — Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and …